The Culture of Carbapenem Overconsumption: Where Does It Begin? Results of a Single-Center Survey.

作者: Bryan T. Mogle , Robert W. Seabury , Zachary Jones , Christopher D. Miller , Jeffrey M. Steele

DOI: 10.1177/0018578718775328

关键词:

摘要: Purpose: The United States has seen an increased consumption of carbapenem antibiotics in recent years. utilization these agents potential negative consequences, including the increasing incidence carbapenem-resistant Enterobacteriaceae. Reasons for rise use among providers acute care hospitals are not well elucidated literature. objectives this study were to identify factors that influence empiric a single academic medical center, and assess therapeutic knowledge pertaining use. Methods: A cross-sectional, single-center, 9-item electronic research survey was developed independently validated by infectious diseases pharmacist physician. distributed email accounts at center. Demographic data, affecting prescription, baseline assessed. Results: Ninety-five 416 responded (response rate 22.8%). Respondents across all levels training with primary roles internal medicine surgery. most important influencing suspected pathogens site infection, drug allergies, history multidrug resistant organisms, severity illness, type local resistance rates. recommendation from selected as likely factor deterring Misconceptions penicillin allergy beta-lactam cross reactivity, rates according institutional antibiogram, comparative efficacy data carbapenems apparent training. Conclusions: Provider misconceptions regarding several appear contribute unnecessary carbapenems. An opportunity exists hospital pharmacists improve prescribing patterns correcting provider through education.

参考文章(11)
Milena McLaughlin, M. Renee Advincula, Michael Malczynski, Chao Qi, Maureen Bolon, Marc H. Scheetz, Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae Antimicrobial Agents and Chemotherapy. ,vol. 57, pp. 5131- 5133 ,(2013) , 10.1128/AAC.00607-13
Michael E. Pichichero, Janet R. Casey, Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngology-Head and Neck Surgery. ,vol. 136, pp. 340- 347 ,(2007) , 10.1016/J.OTOHNS.2006.10.007
C. Dustin Waters, Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support American Journal of Health-System Pharmacy. ,vol. 72, pp. 466- 468 ,(2015) , 10.2146/AJHP140381
Krisztina M. Papp-Wallace, Andrea Endimiani, Magdalena A. Taracila, Robert A. Bonomo, Carbapenems: Past, Present, and Future Antimicrobial Agents and Chemotherapy. ,vol. 55, pp. 4943- 4960 ,(2011) , 10.1128/AAC.00296-11
Jane Frumin, Jason C Gallagher, Allergic Cross-Sensitivity Between Penicillin, Carbapenem, and Monobactam Antibiotics: What Are the Chances? Annals of Pharmacotherapy. ,vol. 43, pp. 304- 315 ,(2009) , 10.1345/APH.1L486
Aoife Fleming, Colin Bradley, Shane Cullinan, Stephen Byrne, Antibiotic Prescribing in Long-Term Care Facilities: A Meta-synthesis of Qualitative Research Drugs & Aging. ,vol. 32, pp. 295- 303 ,(2015) , 10.1007/S40266-015-0252-2
David A Cook, Christopher M Wittich, Wendlyn L Daniels, Colin P West, Ann M Harris, Timothy J Beebe, Incentive and Reminder Strategies to Improve Response Rate for Internet-Based Physician Surveys: A Randomized Experiment Journal of Medical Internet Research. ,vol. 18, ,(2016) , 10.2196/JMIR.6318
James Baggs, Scott K. Fridkin, Lori A. Pollack, Arjun Srinivasan, John A. Jernigan, Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012 JAMA Internal Medicine. ,vol. 176, pp. 1639- 1648 ,(2016) , 10.1001/JAMAINTERNMED.2016.5651
Kellie J. Goodlet, Michael D. Nailor, Necessity of carbapenem use when prescribed per infectious diseases specialists. Diagnostic Microbiology and Infectious Disease. ,vol. 88, pp. 41- 46 ,(2017) , 10.1016/J.DIAGMICROBIO.2017.02.013
Pranita D. Tamma, Maria Virginia Villegas, Use of β-Lactam/β-Lactamase Inhibitors for Extended-Spectrum-β-Lactamase Infections: Defining the Right Patient Population. Antimicrobial Agents and Chemotherapy. ,vol. 61, ,(2017) , 10.1128/AAC.01094-17